Ventas (NYSE:VTR) Earns Outperform Rating from Analysts at Credit Suisse Group

Credit Suisse Group assumed coverage on shares of Ventas (NYSE:VTRGet Rating) in a report released on Wednesday morning, The Fly reports. The brokerage issued an outperform rating on the real estate investment trust’s stock.

Several other analysts have also recently issued reports on VTR. Evercore ISI set a $59.00 target price on Ventas in a research report on Monday. Royal Bank of Canada increased their target price on Ventas from $62.00 to $63.00 in a research report on Friday, May 20th. BMO Capital Markets upgraded Ventas from a market perform rating to an outperform rating and increased their target price for the stock from $57.00 to $67.00 in a research report on Friday, March 11th. Mizuho increased their target price on Ventas from $61.00 to $65.00 and gave the stock a buy rating in a research report on Monday, March 21st. Finally, StockNews.com cut Ventas from a hold rating to a sell rating in a research report on Wednesday, June 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and a consensus target price of $63.00.

NYSE VTR opened at $49.75 on Wednesday. The stock’s 50-day moving average price is $55.54 and its 200-day moving average price is $54.67. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 1.15. Ventas has a 52 week low of $45.44 and a 52 week high of $64.02. The company has a market capitalization of $19.88 billion, a P/E ratio of 127.57, a price-to-earnings-growth ratio of 2.97 and a beta of 1.16.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 14th. Stockholders of record on Friday, July 1st will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 3.62%. The ex-dividend date of this dividend is Thursday, June 30th. Ventas’s payout ratio is 461.55%.

In other news, CEO Debra A. Cafaro sold 17,400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 1st. The stock was sold at an average price of $56.43, for a total value of $981,882.00. Following the completion of the sale, the chief executive officer now directly owns 767,960 shares of the company’s stock, valued at approximately $43,335,982.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Debra A. Cafaro sold 69,602 shares of the firm’s stock in a transaction that occurred on Tuesday, March 29th. The shares were sold at an average price of $63.40, for a total value of $4,412,766.80. The disclosure for this sale can be found here. Insiders sold a total of 104,402 shares of company stock valued at $6,481,975 over the last ninety days. Corporate insiders own 1.30% of the company’s stock.

Several hedge funds have recently modified their holdings of VTR. Riverview Trust Co bought a new stake in shares of Ventas during the 1st quarter worth approximately $25,000. Prospera Financial Services Inc bought a new stake in shares of Ventas during the 1st quarter worth approximately $28,000. US Asset Management LLC bought a new stake in shares of Ventas during the 1st quarter worth approximately $32,000. West Bancorporation Inc. bought a new stake in shares of Ventas during the 1st quarter worth approximately $33,000. Finally, CENTRAL TRUST Co lifted its stake in shares of Ventas by 2,053.8% during the 1st quarter. CENTRAL TRUST Co now owns 560 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 534 shares during the last quarter. 94.02% of the stock is owned by hedge funds and other institutional investors.

Ventas Company Profile (Get Rating)

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.

Further Reading

The Fly logo

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.